"Das REGIOMED Klinikum Coburg ist als Lehrkrankenhaus der Universität Split ein Schwerpunktkrankenhaus der Versorgungsstufe II mit 510 Betten und angegliedertem Dialysezentrum mit 46 Pläzen."

During the past decade, Klinikum Coburg conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 24 clinical trials were completed, i.e. on average, 55.8% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 13 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Coburg" #1 sponsor was "Abbott Medical Devices" with 16 trials, followed by "Biotronik SE & Co. KG" with 7 trials sponsored, "Boston Scientific Corporation" with 5 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 5 trials sponsored and "Stiftung Institut fuer Herzinfarktforschung" with 5 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 51 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Coburg" #1 collaborator was "Abbott Medical Devices" with 3 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "I-Med-Pro GmbH" with 2 trials as a collaborator and "Medtronic" with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 43 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Coburg" are "Atrial Fibrillation" (21 trials), "Heart Failure" (10 trials), "Stroke" (8 trials), "Coronary Artery Disease" (7 trials) and "Arrhythmia" (3 trials). Many other conditions were trialed in "Klinikum Coburg" in a lesser frequency.

Most popular intervention types in "Klinikum Coburg" are "Device" (51 trials), "Drug" (24 trials), "Procedure" (12 trials), "Other" (9 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (7 trials), "cyclophosphamide" (6 trials), "doxorubicin hydrochloride" (5 trials), "vincristine sulfate" (5 trials) and "filgrastim" (4 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Coburg" are 99 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Coburg". undefined are not yet recruiting, 6 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 66 completed trials in Klinikum Coburg, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Coburg, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 31 trials that are defined as “Not Applicable".